Early research (Phase 1)Study completedNCT03293732
What this trial is testing
Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults
Who this might be right for
Flu, Human
Advagene Biopharma Co. Ltd. 36